Medical Facilities Toekomstige groei

Future criteriumcontroles 0/6

De omzet en winst van Medical Facilities zullen naar verwachting dalen met respectievelijk 14.3% en 30% per jaar, terwijl de winst per aandeel naar verwachting zal dalen met 29.1% per jaar.

Belangrijke informatie

-30.0%

Groei van de winst

-29.1%

Groei van de winst per aandeel

Healthcare winstgroei	58.0%
Inkomstengroei	-14.3%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	15 Nov 2024

Recente toekomstige groei-updates

Medical Facilities Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Nov 12

Recent updates

Medical Facilities Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Nov 12

Medical Facilities (TSE:DR) Seems To Use Debt Quite Sensibly

Aug 05

Medical Facilities' (TSE:DR) Dividend Will Be $0.0805

Mar 26

Medical Facilities (TSE:DR) Has Affirmed Its Dividend Of $0.0805

Dec 23

Is Medical Facilities (TSE:DR) Using Too Much Debt?

Sep 14

Is It Too Late To Consider Buying Medical Facilities Corporation (TSE:DR)?

May 13

The Returns At Medical Facilities (TSE:DR) Aren't Growing

Apr 24

Medical Facilities' (TSE:DR) Upcoming Dividend Will Be Larger Than Last Year's

Dec 21

Medical Facilities (TSE:DR) Will Pay A Dividend Of CA$0.07

Sep 24

Is Medical Facilities (TSE:DR) Using Too Much Debt?

Jul 24

Medical Facilities (TSE:DR) Will Pay A Dividend Of CA$0.07

Jun 25

Here's Why It's Unlikely That Medical Facilities Corporation's (TSE:DR) CEO Will See A Pay Rise This Year

May 07

Is Now The Time To Look At Buying Medical Facilities Corporation (TSE:DR)?

Apr 19

Here's How We Evaluate Medical Facilities Corporation's (TSE:DR) Dividend

Mar 29

Medical Facilities (TSE:DR) Has A Somewhat Strained Balance Sheet

Mar 08

Winst- en omzetgroeiprognoses

TSX:DR - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	340	N/A	N/A	N/A	1
12/31/2025	338	13	N/A	N/A	2
12/31/2024	428	19	N/A	N/A	2
9/30/2024	441	20	74	81	N/A
6/30/2024	442	12	59	75	N/A
3/31/2024	445	16	63	78	N/A
12/31/2023	446	19	57	73	N/A
9/30/2023	443	5	52	70	N/A
6/30/2023	440	-5	58	68	N/A
3/31/2023	433	8	56	64	N/A
12/31/2022	425	-4	50	57	N/A
9/30/2022	416	8	58	63	N/A
6/30/2022	410	15	58	64	N/A
3/31/2022	405	4	59	67	N/A
12/31/2021	399	16	67	76	N/A
9/30/2021	395	2	67	75	N/A
6/30/2021	395	9	76	85	N/A
3/31/2021	365	4	112	118	N/A
12/31/2020	364	11	106	113	N/A
9/30/2020	371	36	101	109	N/A
6/30/2020	371	39	93	103	N/A
3/31/2020	397	62	61	72	N/A
12/31/2019	398	44	65	77	N/A
9/30/2019	367	31	63	78	N/A
6/30/2019	374	28	62	79	N/A
3/31/2019	387	11	59	80	N/A
12/31/2018	391	23	60	81	N/A
9/30/2018	420	23	63	83	N/A
6/30/2018	404	18	N/A	79	N/A
3/31/2018	394	25	N/A	85	N/A
12/31/2017	385	21	N/A	80	N/A
9/30/2017	382	38	N/A	79	N/A
6/30/2017	372	35	N/A	88	N/A
3/31/2017	353	15	N/A	76	N/A
12/31/2016	339	10	N/A	78	N/A
9/30/2016	321	-5	N/A	82	N/A
6/30/2016	316	6	N/A	72	N/A
3/31/2016	312	9	N/A	82	N/A
12/31/2015	309	25	N/A	80	N/A
9/30/2015	301	8	N/A	84	N/A
6/30/2015	303	22	N/A	88	N/A
3/31/2015	300	39	N/A	86	N/A
12/31/2014	297	19	N/A	88	N/A
9/30/2014	305	33	N/A	92	N/A
6/30/2014	303	17	N/A	90	N/A
3/31/2014	306	9	N/A	84	N/A
12/31/2013	309	11	N/A	86	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De winst van DR zal naar verwachting de komende 3 jaar dalen ( -30% per jaar).

Winst versus markt: De winst van DR zal naar verwachting de komende 3 jaar dalen ( -30% per jaar).

Hoge groeiwinsten: De winst van DR zal naar verwachting de komende 3 jaar dalen.

Omzet versus markt: De omzet van DR zal naar verwachting de komende 3 jaar dalen ( -14.3% per jaar).

Hoge groei-inkomsten: De omzet van DR zal naar verwachting de komende 3 jaar dalen ( -14.3% per jaar).

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van DR naar verwachting over 3 jaar hoog zal zijn

Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2024/12/22 12:04
Aandelenkoers aan het einde van de dag	2024/12/20 00:00
Inkomsten	2024/09/30
Jaarlijkse inkomsten	2023/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .

Bronnen van analisten

Medical Facilities Corporation wordt gevolgd door 8 analisten. 2 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Neil Maruoka	Canaccord Genuity
Prakash Gowd	CIBC Capital Markets
Douglas Loe	Echelon Wealth Partners Inc.

Medical Facilities Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus EPS estimates fall by 16%

Consensus EPS estimates increase by 32%

Medical Facilities Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Recent updates

Third quarter dividend of CA$0.09 announced

Chief Financial Officer recently sold CA$127k worth of stock

Medical Facilities Corporation Announces Fourth Quarter Dividend, Payable on January 15, 2025

Independent Director recently sold CA$1.6m worth of stock

Sanford Health completed the acquisition of Black Hills Surgical Hospital, Llp from Medical Facilities Corporation (TSX:DR) for US $194 million

Sanford Health completed the acquisition of Black Hills Surgical Hospital, Llp from Medical Facilities Corporation (TSX:DR) for US $194 million

Consensus EPS estimates fall by 16%

New major risk - Revenue and earnings growth

Medical Facilities' (TSE:DR) Earnings Offer More Than Meets The Eye

Sanford Health entered into a definitive agreement to acquire Black Hills Surgical Hospital, Llp from Medical Facilities Corporation (TSX:DR) for US $194 million, subject to customary purchase price adjustments.

New minor risk - Earnings quality

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Medical Facilities Corporation to Report Q3, 2024 Results on Nov 07, 2024

Second quarter dividend of CA$0.09 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Medical Facilities Corporation to Report Q2, 2024 Results on Aug 06, 2024

Medical Facilities (TSE:DR) Is Paying Out A Dividend Of $0.09

Medical Facilities Corporation Announces Second Quarter Dividend, Payable on July 15, 2024

Now 22% overvalued after recent price rise

First quarter 2024 earnings released: EPS: US$0.07 (vs US$0.17 in 1Q 2023)

Medical Facilities Corporation to Report Q1, 2024 Results on May 09, 2024

Fourth quarter dividend of CA$0.081 announced

We Think Medical Facilities' (TSE:DR) Robust Earnings Are Conservative

Consensus EPS estimates increase by 32%

Now 21% overvalued after recent price rise

Medical Facilities Corporation Announces First Quarter Cash Dividend, Payable on April 15, 2024

New major risk - Revenue and earnings growth

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Medical Facilities Corporation, Annual General Meeting, May 09, 2024

Medical Facilities Corporation to Report Q4, 2023 Results on Mar 14, 2024

Now 22% overvalued after recent price rise

Medical Facilities Corporation Announces Fourth Quarter Cash Dividend, Payable on January 15, 2024

Medical Facilities Corporation Appoints Jason Redman as President

Medical Facilities Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Third quarter 2023 earnings: EPS misses analyst expectations

Medical Facilities Corporation to Report Q3, 2023 Results on Nov 09, 2023

Medical Facilities Corporation Announces Third Quarter Dividend, Payable on October 16, 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations

Medical Facilities (TSE:DR) Seems To Use Debt Quite Sensibly

Medical Facilities Corporation to Report Q2, 2023 Results on Aug 10, 2023

Medical Facilities Corporation Announces Second Quarter Dividend, Payable on July 17, 2023

First quarter 2023 earnings released: EPS: US$0.17 (vs US$0.26 loss in 1Q 2022)

Medical Facilities' (TSE:DR) Dividend Will Be $0.0805

Full year 2022 earnings: EPS and revenues miss analyst expectations

Medical Facilities (TSE:DR) Has Affirmed Its Dividend Of $0.0805

Medical Facilities Corporation Announces Fourth Quarter Dividend, Payable on January 16, 2023

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

Third quarter 2022 earnings: EPS misses analyst expectations

Medical Facilities Corporation to Report Q3, 2022 Results on Nov 10, 2022

Medical Facilities Corporation Announces Executive Changes

Independent Director recently bought CA$1.1m worth of stock

Medical Facilities Corporation Announces Third Quarter Dividend, Payable on October 15, 2022

Medical Facilities Corporation (TSX:DR) announces an Equity Buyback for $34.5 million worth of its shares.

Is Medical Facilities (TSE:DR) Using Too Much Debt?

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Medical Facilities Corporation to Report Q2, 2022 Results on Aug 11, 2022

Medical Facilities Corporation Announces Second Quarter 2022 Dividend, Payable on July 15, 2022

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is It Too Late To Consider Buying Medical Facilities Corporation (TSE:DR)?

Medical Facilities Corporation Announces Changes to the Board of Directors of the Corporation

Insufficient new directors

The Returns At Medical Facilities (TSE:DR) Aren't Growing

Medical Facilities Corporation, Annual General Meeting, Jun 21, 2022

Medical Facilities Corporation Announces First Quarter 2022 Cash Dividend, Payable on April 14, 2022

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations